Safety Study of TAK-700 in Subjects With Prostate Cancer.

NCT00569153 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Millennium Pharmaceuticals, Inc.